Table 2. OS Based on Metastasis Site (N = 318).
| Topography of metastases | Number | Events | Median survival (months) | P |
|---|---|---|---|---|
| Bone metastases | 0.460 | |||
| No | 129 | 66 | 27.6 | |
| Yes | 179 | 101 | 29.0 | |
| Liver metastases | 0.120 | |||
| No | 222 | 115 | 30.1 | |
| Yes | 93 | 55 | 22.5 | |
| CNS metastases | 0.022* | |||
| No | 297 | 158 | 29.1 | |
| Yes | 18 | 12 | 6.9 | |
| Cutaneous-subcutaneous metastases | 0.029* | |||
| No | 271 | 140 | 29.4 | |
| Yes | 37 | 27 | 17.2 | |
| Lung metastases | 0.006* | |||
| No | 216 | 109 | 30.1 | |
| Yes | 93 | 58 | 21.4 |
*P < 0.05. OS: overall survival; CNS: central nervous system.